PREAMBLELicense Agreement • May 9th, 2006 • Myogen Inc • Pharmaceutical preparations • New York
EXHIBIT 10.34 [DATE] VIA HAND DELIVERY [Name] Myogen, Inc. 7575 West 103rd Avenue, Suite 102 Westminster, CO 80021 Re: Employment and Retention Agreement Dear [Name]: In consideration of your continued employment as [Position], Myogen, Inc. (the...Employment and Retention Agreement • May 9th, 2006 • Myogen Inc • Pharmaceutical preparations • Colorado
February 21, 2006 VIA HAND DELIVERY Michael R. Bristow, M.D., Ph.D. Myogen, Inc. 7575 West 103rd Avenue, Suite 102 Westminster, CO 80021 Re: Employment and Retention Agreement Dear Dr. Bristow:Employment and Retention Agreement • May 9th, 2006 • Myogen Inc • Pharmaceutical preparations • Colorado
In consideration of your employment as Founder and Scientific Advisor, Myogen, Inc. (the “Company”) is pleased to offer you the following agreement regarding your employment with the Company (the “Agreement”). This Agreement amends and supersedes any and all prior agreements with respect to your employment terms, including but not limited to, that certain Employment and Retention Agreement dated, October 1, 2003 and that certain Employee Proprietary Information and Inventions Agreement dated as of September 23, 1998 and effective May 1, 1998.
EXHIBIT 10.38 [..**..] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934,...Distribution Agreement • May 9th, 2006 • Myogen Inc • Pharmaceutical preparations • New York
RETIREMENT, CONSULTING AND GENERAL RELEASE AGREEMENTRetirement, Consulting and General Release Agreement • May 9th, 2006 • Myogen Inc • Pharmaceutical preparations • Colorado
This Retirement, Consulting and General Release Agreement (“Agreement”) is made and entered into by and between John R. Julian, (“Julian” or “you”), on one side, and Myogen, Inc. (“Myogen” or “the Company”), on the other side, as of the Effective Date defined in Section 13 herein.
